Printer Friendly

Delcath elects Dr Jennifer Simpson as president & CEO.

M2 EQUITYBITES-May 27, 2015-Delcath elects Dr Jennifer Simpson as president & CEO

(C)2015 M2 COMMUNICATIONS http://www.m2.com

The board of directors of Delcath Systems (NasdaqCM:DCTH), a medical device company, revealed on Tuesday that it has appointed Jennifer Simpson, PhD, MSN, CRNP as its president and chief executive officer with immediate effect.

In 2012, Dr Simpson joined Delcath as executive vice president of Global Marketing, served as interim president and chief executive officer of Delcath since September 2014 as well as its interim co-president and co-chief executive officer from September 2013 to September 2014.

Dr Simpson recently served as vice president, Global Marketing, Oncology Brand Lead at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company.

Previously, Dr Simpson has worked as vice president, Product Champion, associate vice president, Product Champion at ImClone, product director, Oncology Therapeutics Marketing at Ortho Biotech as well as spent a decade as a hematology/oncology nurse practitioner and educator at the start of her career.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:May 27, 2015
Words:175
Previous Article:The Rite Aid Foundation awards USD1.3m to Folds of Honor in an aid to education.
Next Article:Intellipharmaceutics International's Rexista Oxycodone XR extended-release tablets development programme awarded US FDA's fast track designation.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters